Libbe Englander, CEO of Pharm3r, has been named one of the 40 top innovators in healthcare by MM&M. MM&M cited her work in integrating “artificial intelligence into real world data sources to evaluate drug and device safety – and thereby improve patient outcomes”. Pharm3r’s product suite can improve outcomes in quality assurance, risk assessment, patient care and insurance underwriting.